Chemical Compound

(2S)-5-amino-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2,4-diamino-4-oxo-butanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methyl-butanoyl]amino]-3-hydroxy-propanoyl]amino]-3-methyl-pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxo-pentanoic acid

CAS Registry Number 211439-12-2
(2S)-5-amino-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2,4-diamino-4-oxo-butanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methyl-butanoyl]amino]-3-hydroxy-propanoyl]amino]-3-methyl-pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxo-pentanoic acid 结构式
Primary record

(2S)-5-amino-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2,4-diamino-4-oxo-butanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methyl-butanoyl]amino]-3-hydroxy-propanoyl]amino]-3-methyl-pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxo-pentanoic acid

库存
5,503 克
纯度
98.4 %
CAS
211439-12-2

化合物标识与属性

CAS
211439-12-2
PubChem CID
9832404
SMILES
CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC(=O)[C@H](CC(=O)N)N
Canonical SMILES
CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O

名称与同义词

  • Davunetide
  • Davunetida
  • NAP peptide
  • davunetidum
  • NAPVSIPQ peptide
  • D-NAP peptide
  • NAPVSIPQ
  • NAP (peptide)
  • AL108 cpd
  • AL208 cpd
  • 211439-12-2
  • GF00K3IIWE
  • Davunetide (USAN/INN)
  • Davunetide [USAN:INN]
  • RefChem:585209
  • UNII-GF00K3IIWE
  • AL-108
  • AL-208
  • SCHEMBL239737
  • orb1705043
  • CHEMBL2103826
  • AL 108
  • AL 208
  • AL-408
  • CHEBI:177706
  • BDBM627981
  • Asn-Ala-Pro-Val-Ser-Ile-Pro-Gln
  • C36H60N10O12
  • ZINC85540112
  • AKOS040744852
  • Activity-Dependent Neuroprotective Protein Fragment 74-81, mouse, rat
  • CID9832404
  • DB12613
  • CID 9832404
  • CID:9832404
  • CVD-0019438
  • BN172353
  • DA-50204
  • FI109792
  • MS-31531
  • SID:152186727
  • HY-105066
  • CS-0024867
  • NS00073018
  • J1.071.405B
  • L-Asparaginyl-L-alanyl-L-prolyl-L-valyl-L-seryl-L-isoleucyl-L-prolyl-L-glutamine
  • D09401
  • G13180
  • Influenza pr8 hemagglutinin peptide(110-119)
  • A974572
  • C425904
  • 132031-50-6
  • J-013876
  • L-Glutamine, L-asparaginyl-L-alanyl-L-prolyl-L-valyl-L-seryl-L-isoleucyl-L-prolyl-
  • Q27279075
  • (2S)-5-amino-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2,4-diamino-4-oxobutanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid
  • H2N-L-Asn-L-Ala-L-Pro-L-Val-L-Ser-L-Ile-L-Pro-L-Gln-COOH
  • Human activity-dependent neuroprotective protein (ADNP)-(354-361)-peptide
  • L-Glutamine,L-asparaginyl-L-alanyl-L-prolyl-L-valyl-L-seryl-L-isoleucyl-L-prolyl-
  • H-Ser-Phe-Glu-Arg-Phe-Glu-Ile-Phe-Pro-Lys-OH trifluoroacetate sa lt
  • Influenza PR8 Hemagglutinin Peptide (110-119) trifluoroacetate salt
  • NAP
  • (2S)-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-AMINO-3-CARBAMOYLPROPANAMIDO]PROPANOYL]PYRROLIDIN-2-YL]FORMAMIDO}-3-METHYLBUTANAMIDO]-3-HYDROXYPROPANAMIDO]-3-METHYLPENTANOYL]PYRROLIDIN-2-YL]FORMAMIDO}-4-CARBAMOYLBUTANOIC ACID
  • (2S)-5-amino-2-(((2S)-1-((2S,3S)-2-(((2S)-2-(((2S)-2-(((2S)-1-((2S)-2-(((2S)-2,4-diamino-4-oxobutanoyl)amino)propanoyl)pyrrolidine-2-carbonyl)amino)-3-methylbutanoyl)amino)-3-hydroxypropanoyl)amino)-3-methylpentanoyl)pyrrolidine-2-carbonyl)amino)-5-oxopentanoic acid
  • (2S)-5-amino-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2,4-diamino-4-oxo-butanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methyl-butanoyl]amino]-3-hydroxy-propanoyl]amino]-3-methyl-pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxo-pentanoic acid
  • 5-amino-2-[[1-[2-[[2-[[2-[[1-[2-[(2,4-diamino-4-oxobutanoyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid